FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to toxicology and ecology, and concerns modeling of chronic coagulopathy. For this, experimental animals are injected with a solution of ammonium paramolybdate at a dose of 50 mg/kg per metal, wherein a unit of solution equal to 0.3 ml contains 5 mg of molybdenum, for two months daily, once a day into the stomach.
EFFECT: method allows adequate reproduction of a model of chronic coagulopathy in experimental animals by optimal dosage and duration of exposure to molybdenum.
1 cl, 1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREVENTING CHRONIC MOLYBDENUM COAGULOPATHY | 2020 |
|
RU2739690C1 |
METHOD OF MODELING CHRONIC TOXIC COAGULOPATHY IN RATS | 2023 |
|
RU2800860C1 |
METHOD FOR MODELING CHRONIC TOXIC COAGULOPATHY IN RATS IN EXPERIMENT | 2022 |
|
RU2785847C1 |
METHOD FOR MODELING CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2017 |
|
RU2661722C1 |
METHOD FOR SIMULATING CHROMIUM-INDUCED COAGULOPATHY IN EXPERIMENTAL RATS | 2020 |
|
RU2743812C1 |
METHOD FOR PREVENTION OF CHRONIC SUBLEME COAGULOPATHY IN RATS IN EXPERIMENT | 2022 |
|
RU2788609C1 |
METHOD FOR PREVENTION OF TOXIC COAGULOPATHY IN RATS | 2022 |
|
RU2794030C1 |
METHOD FOR PREVENTING CHRONIC LEAD COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2019 |
|
RU2706386C1 |
METHOD FOR PREVENTION OF CHRONIC TOXIC COAGULOPATHY IN EXPERIMENTAL ANIMALS | 2018 |
|
RU2683723C1 |
METHOD FOR PREVENTION OF NEPHROTOXIC EFFECT OF MOLYBDENUM | 2020 |
|
RU2786641C2 |
Authors
Dates
2021-04-21—Published
2020-01-10—Filed